The Changing TAVR Landscape

New Hope for TAVR: Overcoming Challenges for Women & Patients With Small Annuli

MinuteCE®
ReachMD Healthcare Image
Media formats available:
Details
Episodes
Presenters
Comments
  • Overview

    "The Changing TAVR Landscape" is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape. Join our experts as they discuss topics on patient identification ranging from the use of echocardiography to identify symptomatic severe aortic stenosis patients to challenging case discussions, device durability, and up-to-date clinical trial data.

  • Disclosure of Relevant Financial Relationships

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Hemal Gada, MD
    President, Heart and Vascular Institute
    Co-Director, Structural Heart Program
    UPMC Central PA
    Harrisburg, PA

    Research: Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Inc.
    Consulting Fees: Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Inc.

    Renuka Jain, MD
    Director of Echocardiography
    Aurora St. Luke’s
    Milwaukee, WI

    Research: GE HealthCare
    Consulting Fees: Medtronic Inc.

    Pam Taub, MD, FACC, FASPC
    Cardiologist and Professor of Medicine
    UC San Diego
    La Jolla, CA

    Consulting Fees: Amarin, Amgen, Bayer, Boehringer Ingelheim, Esperion, Medtronic, Novartis, Novo Nordisk, Sanofi
    Ownership Interest: Epirium Bio

    Steven Yakubov, MD, MSCAI, FACC
    System Chief
    Structural Heart Disease
    Riverside Methodist Hospital, Ohio Health
    Columbus, OH

    Research: Boston Scientific, Medtronic, Inc.
    Consulting Fees: Boston Scientific, Medtronic, Inc.

    Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI
    Professor of Medicine (Cardiology)
    and Population Health Science and Policy
    Director, Women’s Heart and Vascular Center
    Mount Sinai Fuster Heart Hospital
    Icahn School of Medicine at Mount Sinai
    New York, NY

    Research: Abbott, Abiomed, Affluent Medical, Alleviant Medical, Amgen, AM-Pharma, Arena, AstraZeneca, AtriCure Inc., Biosensors, Biotronik, Boston Scientific, Bristol Myers Squibb, CardiaWave, CeloNova, CERC, Chiesi, Cleerly Health Inc., Concept Medical, Cytosorbents, Daiichi Sankyo, Duke, Element Science, Essential Medical, Faraday, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere, Medtelligence, Medtronic, MJH Healthcare, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Population Health Research Institute, Protembis, RecCor Medical Inc., RenalPro, RM Global, Sanofi, Shockwave, Vivasure, Zoll
    Ownership Interest: Equity <1% in: Elixir Medical, Stel, CntrolRad (spouse)
    Consulting Fees: Affluent Medical, Boehringer Ingelheim, Cardiovascular Research Foundation (CRF), Cordis, Daiichi Sankyo Brasil, E.R. Squibb & Sons, Esperion Science/Innovative Biopharma, Europa Group/Boston Scientific, Gaffney Events, Educational Trust, Henry Ford Health Cardiology, Ionis Pharmaceuticals, Lilly and Company, MedCon International, Novartis, NovoNordisk, PeerView Institute for Medical Education, TERUMO Europe N.V., Vectura, VoxMedia, WebMD, IQVIA, Radcliffe, TARSUS Cardiology
    Honorarium: JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program)

    Ashish Aneja, MD
    Associate Professor of Medicine
    Case Western Reserve University
    MetroHeath Campus
    Cleveland, OH

    Consulting Fees: Bristol Myers Squibb, Medtronic

    Deepak Talreja, MD, FACC
    Clinic Chief of Cardiology, Sentara Health
    Assistant Professor, Eastern Virginia Medical School
    Norfolk, VA

    Speakers Bureaus: Bristol Myers Squibb, Camzyos, AstraZeneca, Farxiga, Bayer, Boehringer-Inlgeheim/Lilly, Kiniksa, Arcalyst, Medicure, Zoll, Novo Nordisk, Acarix
    Proctor: Medtronic, Edwards, Life Sciences, Abbott, Portoco 

    Elana Koss, MD
    Director
    North Shore University Hospital
    Manhasset, NY

    Research: Edwards Lifescience, Medtronic, Abbott
    Consulting Fees: Edward Life Science, Medtronic, Abbott

    Anene Ukaigwe, MD
    Interventional and Structural Cardiologist
    University Hospital, Harrington Heart and Vascular Institute
    Cleveland, OH

    Consulting Fees: Medtronic, Inc.

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has nothing to disclose.
    • Howard Green has nothing to disclose.
    • Samantha Keehn has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Tim Person has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
    • Mario Trucillo, PhD, MS has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Recognize the symptoms and biomarkers of aortic stenosis to help improve diagnosis
    • Review the clinical trial data on the safety and efficacy of transcatheter aortic valve replacement (TAVR)
    • Select appropriate patients for referral to specialist care
    • Effectively employ the use of echocardiography in the diagnosis of patients with aortic stenosis
  • Target Audience

    This activity is designed to meet the educational needs of General Cardiologists, Primary Care Professionals, Nurses, and PA’s.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 1.00 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 1/24/2025. PAs should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.

  • Commercial Support

    This activity is supported by an independent educational grant from Medtronic.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Register

We're glad to see you're enjoying Medtelligence…
but how about a more personalized experience?

Register for free